Diagnostic challenge of zygomycosis in compromised hosts

Medical Mycology

Volumn 44, Issue 1, 2006, Pages 19-24

  Wang, Jiun Ling ^a   Hsiao, Cheng Hsiang ^a   Chang, Shan Chwen ^a,b   Hsueh, Po Ren ^a   Chen, Yee Chun ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Diabetes mellitus; Haematological disease; Prognosis; Risk factors; Zygomycosis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; INFECTION RISK; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCORMYCOSIS; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ZYGOMYCETES;

AGED; DIABETES COMPLICATIONS; FEMALE; HEMATOLOGIC DISEASES; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; STEROIDS; ZYGOMYCOSIS;

ZYGOMYCETES;

EID: 31344462111     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780500130341     Document Type: Article

References (22)

1. Ribes, JA and Vanover-Sams, CL and Baker, DJ. (2000) Zygomycetes in human disease Clin Microbiol Rev, 13, pp. 236-301.
2. Prabhu, RM and Patel, R. (2004) Mucormycosis and entomophthoramycosis: A review of the clinical manifestations, diagnosis and treatment Clin Microbiol Infect, 10, pp. S31-S47.
3. Parfrey, NA. (1986) Improved diagnosis and prognosis of mucormycosis: A clinicopathologic study of 33 cases Medicine (Baltimore), 65, pp. 113-23.
4. Kontoyiannis, DP and Wessel, VC and Bodey, GP and Rolston, KV. (2000) Zygomycosis in the 1990s in a tertiary-care cancer center Clin Infect Dis, 30, pp. 851-856.
5. Funada, H and Matsuda, T. (1996) Pulmonary mucormycosis in a hematology ward Intern Med, 35, pp. 540-554.
6. Pagano, L and Ricci, P and Tonso, A and (1997) Mucormycosis in patients with haematological malignancies: A retrospective clinical study of 37 cases Br J Haematol, 99, pp. 331-336.
7. Denning, DW and Kibbler, CC and Barnes, RA. (2003) British Society for Medical Mycology. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections Lancet Infect Dis, 3, pp. 230-240.
8. Walsh, TJ and Pappas, P and Winston, DJ and (2002) Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever N Engl J Med, 346, pp. 225-234.
9. Sun, QN and Fothergill, AQ and McCarthy, DI and Rinaldi, MG and Graybill, JR. (2002) In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes Antimicrob Agents Chemother, 46, pp. 1581-1582.
10. Dannaoui, E and Meletiadis, J and Mouton, JW and (2003) In vitro susceptibilities of zygomycetes to conventional and new antifungals J Antimicrob Chemother, 51, pp. 45-52.
11. Denning, DW. (2003) Echinocandin antifungal drugs Lancet, 362, pp. 1142-1151.
12. Larone, DH.(2002) Medically Important Fungi: A Guide to Identification 4th Edition. Washington D. C.: ASM Press.
13. Ascioglu, S and Rex, JH and de Pauw, B and (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus Clin Infect Dis, 34, pp. 7-14.
14. Ebright, JR and Pace, MT and Niazi, AF. (2001) Septic thrombosis of the cavernous sinuses Arch Intern Med, 161, pp. 2671-2676.
15. Talmi, YP and Goldschmied-Reouven, A and Bakon, M and (2002) Rhino-orbital and rhino-orbito-cerebral mucormycosis Otolaryngol Head Neck Surg, 127, pp. 22-31.
16. Chakrabarti, A and Das, A and Sharma, A and (2001) Ten years' experience in zygomycosis at a tertiary care centre in India J Infect, 42, pp. 261-266.
17. Abzug, MJ and Gardner, S and Glode, MP and (1992) Heliport-associated nosocomial mucormycoses Infect Control Hosp Epidemiol, 13, pp. 325-326.
18. Paydas, S and Yavuz, S and Disel, U and (2003) Mucormycosis of the tongue in a patient with acute lymphoblastic leukemia: A possible relation with use of a tongue depressor Am J Med, 114, pp. 618-620.
19. Agger, WA and Maki, DG. (1978) Mucormycosis. A complication of critical care Arch Intern Med, 138, pp. 925-927.
20. Yohai, RA and Bullock, JD and Aziz, AA and Markert, RJ. (1994) Survival factors in rhino-orbital-cerebral mucormycosis Surv Ophthalmol, 39, pp. 3-22.
21. Marty, FM and Cosimi, LA. (2004) Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants N Engl J Med, 350, pp. 951-952.
22. Imhof, A and Balajee, SA and Fredricks, DN and Englund, JA and Marr, KA. (2004) Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole Clin Infect Dis, 39, pp. 743-746.